BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16220970)

  • 1. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
    Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
    J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
    Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
    J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
    Yue EW; Wayland B; Douty B; Crawley ML; McLaughlin E; Takvorian A; Wasserman Z; Bower MJ; Wei M; Li Y; Ala PJ; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem; 2006 Sep; 14(17):5833-49. PubMed ID: 16769216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric synthesis of the (S)-1,1-dioxido-isothiazolidin-3-one phosphotyrosine mimetic via reduction of a homochiral (R)-oxido-isothiazolidin-3-one.
    Combs AP; Glass B; Galya LG; Li M
    Org Lett; 2007 Mar; 9(7):1279-82. PubMed ID: 17338536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
    Sparks RB; Polam P; Zhu W; Crawley ML; Takvorian A; McLaughlin E; Wei M; Ala PJ; Gonneville L; Taylor N; Li Y; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem Lett; 2007 Feb; 17(3):736-40. PubMed ID: 17097290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.
    Douty B; Wayland B; Ala PJ; Bower MJ; Pruitt J; Bostrom L; Wei M; Klabe R; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP; Yue EW
    Bioorg Med Chem Lett; 2008 Jan; 18(1):66-71. PubMed ID: 18037290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
    Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
    Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
    J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
    Liu G; Szczepankiewicz BG; Pei Z; Janowick DA; Xin Z; Hajduk PJ; Abad-Zapatero C; Liang H; Hutchins CW; Fesik SW; Ballaron SJ; Stashko MA; Lubben T; Mika AK; Zinker BA; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 May; 46(11):2093-103. PubMed ID: 12747781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics.
    Ala PJ; Gonneville L; Hillman MC; Becker-Pasha M; Wei M; Reid BG; Klabe R; Yue EW; Wayland B; Douty B; Polam P; Wasserman Z; Bower M; Combs AP; Burn TC; Hollis GF; Wynn R
    J Biol Chem; 2006 Oct; 281(43):32784-95. PubMed ID: 16916797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering.
    Erlanson DA; McDowell RS; He MM; Randal M; Simmons RL; Kung J; Waight A; Hansen SK
    J Am Chem Soc; 2003 May; 125(19):5602-3. PubMed ID: 12733877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B.
    Ala PJ; Gonneville L; Hillman M; Becker-Pasha M; Yue EW; Douty B; Wayland B; Polam P; Crawley ML; McLaughlin E; Sparks RB; Glass B; Takvorian A; Combs AP; Burn TC; Hollis GF; Wynn R
    J Biol Chem; 2006 Dec; 281(49):38013-21. PubMed ID: 17028182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition.
    Hussain M; Ahmed V; Hill B; Ahmed Z; Taylor SD
    Bioorg Med Chem; 2008 Jul; 16(14):6764-77. PubMed ID: 18555687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
    Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
    Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
    Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
    Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.
    Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug.
    Boutselis IG; Yu X; Zhang ZY; Borch RF
    J Med Chem; 2007 Feb; 50(4):856-64. PubMed ID: 17249650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
    Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
    Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.